Infection Prevention and Control

IDSA Comments to HELP Committee on Long COVID

Impact of Reduction in Access to Safe and Legal Abortion on ID Complication Fact Sheet

IDSA fact sheet covering the impact and ID complications that result from reducing access to safe and legal abortions.

IDSA Comments on Medical Device Supply Chain Resilience

IDSA provides recommendations to the administrations for building medical device supply chain resilience

IDSA Comments on FY2023 IPPS Proposed Rule

IDSA comments on CMS proposals including public health emergency data collection, antibiotic use and resistance reporting, and quality measures.

IDSA Comments on HHS National Vector-Borne Disease Strategy RFI

IDSA submitted comments to the Department of Health and Human Services with recommendations for developing a national strategy for researching, surveilling, diagnosing, and treating vector-borne diseases.

IDSA Comments on CDC HCP Guidelines

IDSA submitted comments to the CDC on HCP guidelines to include more gender-inclusive language.

FR Notice National Action Plan

IDSA submits comments to Health and Human Services (HHS) on the National Action Plan to Prevent Health Associated Infections (HAIs).

IDSA and SHEA Submit Joint Comments to Federal Health Safety Agency on Respiratory Protective Devices (PDF)

IDSA and SHEA submitted comments to the US National Institute for Occupational Safety and Health (NIOSH) on respiratory protective devices (RPDs) used in health care.

IDSA Comments to USPSTF Draft Recommendation Statement on Screening for HBV Infection (PDF)

IDSA supports the US Preventive Services Task Force (USPSTF) grade "B" recommendation to screen for Hepatitis B Virus (HBV) in adults at high risk for infection.

IDSA Comments on Pulmonary Tuberculosis: Developing Drugs for Treatment (PDF)

IDSA submitted comments to FDA's draft guidance for industry entitled "Pulmonary Tuberculosis: Developing Drugs for Treatment." IDSA applauded FDA's draft guidance as a major step forward for the clinical development of improved tuberculosis treatment regimens and providing much-needed clarity for sponsors interested in TB product development.

Joint IDSA APIC SHEA Comments on Federal Guidance on PPE (PDF)

IDSA submitted a joint comment letter with the Association of Professional in Infection Control and Epidemiology (APIC) and the Society for Healthcare Epidemiology of America (SHEA) on federal guidance regarding personal protective equipment (PPE) of healthcare workers in treating suspected or confirmed cases of H1N1 influenza.